Administering the noble gas argon during cardiopulmonary resuscitation
AssigneesVanderbilt University, The Medical College of Wisconsin, Inc.
InventorsMatthias L. Riess, Demetris Yannopoulos, Tom P. Aufderheide
Life of this patent
Estimating the term…
Abstract
Method of treating an individual following a period of ischemia are provided. The methods include administering inhaled agents postconditioning to the individual and optionally simultaneously performing cardiopulmonary resuscitation. The inhaled agents include at least one noble gas.
Claims19
A method of treating an individual following a period of ischemia, the method comprising:
- administering inhaled agent postconditioning, the inhaled agent comprising at least one non-anesthetic noble gas;
- and
- performing cardiopulmonary resuscitation simultaneously with the step of administering inhaled agent postconditioning;
- wherein the inhaled agent does not include any volatile anesthetics;
- and
- wherein the inhaled agent includes at least 50% of the at least one non-anesthetic noble gas.
A method to reduce injury of cells after a period of ischemia the method comprising:
- administering non-anesthetic inhaled agent postconditioning;
- and
- performing cardiopulmonary resuscitation simultaneously with the step of administering non-anesthetic inhaled agent postconditioning;
- wherein the inhaled agent comprises at least one non-anesthetic noble gas;
- wherein the inhaled agent includes at least 50% of the at least one non-anesthetic noble gas;
- and
- wherein the inhaled agent does not include any volatile anesthetics.
A method performing cardiopulmonary resuscitation to an individual comprising:
- repeatedly compressing the individual's chest, wherein the chest is compressed during a compression phase followed by a decompression or relaxation phase;
- and
- simultaneously with the compressing step, administering non-anesthetic inhaled agent postconditioning to the individual receiving cardiopulmonary resuscitation;
- wherein the inhaled agent comprises at least one non-anesthetic noble gas;
- and
- wherein the inhaled agent includes at least 50% of the at least one non-anesthetic noble gas.
Dependencies are inferred from the claim text.